Alivus Life Sciences Ltd.

Net sales declined -9.34%  to  Rs. 5092.99 million from Rs. 5617.61 millions.Net profit declined -7.22% to Rs. 1068.78 millions from Rs. 1152.01 millions.Operating Profit reported a sharp decline to 1536.59 millions from 1694.26 millions in the corresponding previous quarter.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202209	202109	% Var	202209	202109	% Var	202203	202103	% Var
Sales	5092.99	5617.61	-9.34	9991.69	10866.58	-8.05	21232.14	18851.65	12.63
Other Income	100.20	20.89	379.66	195.13	60.75	221.20	147.04	8.11	1713.07
PBIDT	1536.59	1694.26	-9.31	3099.20	3338.60	-7.17	6307.64	5918.85	6.57
Interest	1.33	72.26	-98.16	2.68	277.76	-99.04	279.62	875.47	-68.06
PBDT	1535.26	1622.00	-5.35	3096.52	3060.84	1.17	6028.02	5043.38	19.52
Depreciation	99.35	96.65	2.79	198.14	185.84	6.62	378.77	333.94	13.42
PBT	1435.91	1525.35	-5.86	2898.38	2875.00	0.81	5649.25	4709.44	19.96
TAX	367.13	373.34	-1.66	742.27	713.86	3.98	1462.01	1193.63	22.48
Deferred Tax	28.20	7.91	256.51	41.05	26.00	57.88	85.74	66.17	29.58
PAT	1068.78	1152.01	-7.22	2156.11	2161.14	-0.23	4187.24	3515.81	19.10
Equity	245.05	245.05	0.00	245.05	245.05	0.00	245.05	19.60	1150.26
PBIDTM(%)	30.17	30.16	0.04	31.02	30.72	0.96	29.71	31.40	-5.38